Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR ‐Preserved analysis

ConclusionIn EMPEROR-Preserved, LRTI was frequent and associated with a poor prognosis. Empagliflozin was associated with a reduced risk of LRTI compared to placebo.

Source: European Journal of Heart Failure - March 5, 2024 Category: Cardiology Authors: Jo ão Pedro Ferreira, Faiez Zannad, Milton Packer, Gerasimos Filippatos, Stuart J. Pocock, Francisco Vasques‐Nóvoa, Michael Böhm, Javed Butler, Stefan Anker Tags: Research Article Source Type: research